179 related articles for article (PubMed ID: 6617728)
1. Pharmacokinetics of ketanserin in man.
Reimann IW; Okonkwo PO; Klotz U
Eur J Clin Pharmacol; 1983; 25(1):73-6. PubMed ID: 6617728
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of the 5-HT2 receptor antagonist ketanserin in man.
Trenk D; Mosler A; Kirch W; Meinertz T; Jähnchen E
J Cardiovasc Pharmacol; 1983; 5(6):1034-9. PubMed ID: 6196551
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ketanserin in patients with essential hypertension.
Persson B; Pettersson A; Hedner T
Eur J Clin Pharmacol; 1987; 32(3):259-65. PubMed ID: 3595699
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.
Hedner T; Pettersson A; Persson B
J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.
Heykants J; Van Peer A; Woestenborghs R; Gould S; Mills J
Eur J Clin Pharmacol; 1986; 31(3):343-50. PubMed ID: 3792432
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
Klotz U; Müller-Seydlitz P; Heimburg P
Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of azapropazone following single oral and intravenous doses.
Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of antihypertensive action of ketanserin in man.
Reimann IW; Frölich JC
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):381-3. PubMed ID: 6135489
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of propranolol on the steady-state plasma levels of ketanserin.
Trenk D; Lühr A; Radkow N; Jähnchen E
Arzneimittelforschung; 1985; 35(8):1286-8. PubMed ID: 2934070
[TBL] [Abstract][Full Text] [Related]
11. Ketanserin pharmacokinetics in patients with renal failure.
Barendregt JN; Van Peer A; Van Der Hoeven JG; Van Oene JC; Tjandra YI
Br J Clin Pharmacol; 1990 Jun; 29(6):715-23. PubMed ID: 2378791
[TBL] [Abstract][Full Text] [Related]
12. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of ketanserin.
Persson B; Heykants J; Hedner T
Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.
Morgan DJ; Paull JD; Richmond BH; Wilson-Evered E; Ziccone SP
Br J Clin Pharmacol; 1986 Nov; 22(5):587-93. PubMed ID: 3790406
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.
Williams FM; Leeser JE; Rawlins MD
Br J Clin Pharmacol; 1986 Sep; 22(3):301-8. PubMed ID: 3768242
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
Bastain W; Boyce MJ; Stafford LE; Morton PB; Clarke DA; Marlow HF
Eur J Clin Pharmacol; 1988; 34(5):469-73. PubMed ID: 2904884
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
